CT
Contineum Therapeutics, Inc. (CTNM)
NASDAQ·Healthcare·Biotechnology
$14.55
+2.75%
Mkt Cap $525.65M
Analyst Ratings
Buy
1
Hold
1
Sell
0
Price Target (9 analysts)
$17.33
Range $14.00 – $22.00
Implied Upside
+19.1%
Consensus $17.33 vs current $14.55
NASDAQ·Healthcare·Biotechnology
$14.55
+2.75%
Mkt Cap $525.65M
Buy
1
Hold
1
Sell
0
Price Target (9 analysts)
$17.33
Range $14.00 – $22.00
+19.1%
Consensus $17.33 vs current $14.55